DCDGX
Price
$10.78
Change
+$0.27 (+2.57%)
Updated
May 8 closing price
Net Assets
76.91M
WCMLX
Price
$11.80
Change
+$0.13 (+1.11%)
Updated
May 8 closing price
Net Assets
42.14M
Ad is loading...

DCDGX vs WCMLX

Header iconDCDGX vs WCMLX Comparison
Open Charts DCDGX vs WCMLXBanner chart's image
Dunham Small Cap Growth C
Price$10.78
Change+$0.27 (+2.57%)
VolumeN/A
Net Assets76.91M
WCM Small Cap Growth Institutional
Price$11.80
Change+$0.13 (+1.11%)
VolumeN/A
Net Assets42.14M
DCDGX vs WCMLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCDGX vs. WCMLX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCDGX is a Buy and WCMLX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
DCDGX has more cash in the bank: 76.9M vs. WCMLX (42.1M). DCDGX (0.00) and WCMLX (0.00) have matching dividends . DCDGX was incepted earlier than WCMLX: DCDGX (20 years) vs WCMLX (6 years). DCDGX (2.33) is less costly to investors than WCMLX (1.86). DCDGX is a more actively managed with annual turnover of: 100.00 vs. WCMLX (83.00). DCDGX has a lower initial minimum investment than WCMLX: DCDGX (5000) vs WCMLX (100000). DCDGX annual gain was more profitable for investors over the last year : -4.49 vs. WCMLX (-6.86). WCMLX return over 5 years is better than : 21.31 vs. DCDGX (-13.06).
DCDGXWCMLXDCDGX / WCMLX
Total Expense Ratio2.330.99235%
Annual Report Gross Expense Ratio2.331.86125%
Fund Existence20 years6 years-
Gain YTD-12.437-9.253134%
Front LoadN/AN/A-
Min. Initial Investment50001000005%
Min. Initial Investment IRAN/AN/A-
Net Assets76.9M42.1M183%
Annual Yield % from dividends0.000.00-
Returns for 1 year-4.49-6.8665%
Returns for 3 years15.9115.89100%
Returns for 5 years-13.0621.31-61%
Returns for 10 years-33.08N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RFNAX79.550.29
+0.37%
American Funds Fundamental Invs R1
RAGHX25.73N/A
N/A
Virtus KAR Health Sciences A
LVOFX17.92N/A
N/A
Lord Abbett Value Opportunities F
HSCCX2.36N/A
N/A
Carillon Eagle Small Cap Growth C
MKDCX24.35N/A
N/A
BlackRock Emerging Mkts K